Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xinshenning (心神宁) is a traditional Chinese medicine product formulated as tablets or capsules and primarily marketed under the name "Changtai Xinshenning Pian" or "Changtai Xinshenning Tablets." It is used for the relief of insomnia and symptoms such as irritability, dream-disturbed sleep, fatigue, and poor appetite. The formulation is indicated for conditions described in traditional Chinese medicine as heart, liver, and blood deficiency leading to insomnia and restlessness. The product is not a single chemical entity but rather a multi-ingredient herbal supplement; specific active ingredients are not clearly listed in available English-language sources. Its mechanism of action aligns with traditional Chinese medical principles rather than modern pharmacological targets. It is manufactured by companies such as Changtai Pharmaceutical.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on xinshenning.